#JPM19 starts with Eli Lilly's $8B buyout of Loxo Oncology — so who's next?
Eli Lilly $LLY has paid $8 billion to jump the queue and take a leading role in an emerging — though still small — field of oncology.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
